Effect of Immunomodulatory Treatment on IVF (in Vitro Fertilization) Outcomes in Patients With KIR AA Genotype

Clinical trial NCT06264206 · COMPLETED

Trial details

NCT number: NCT06264206
Sponsor: Calla IVF Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Immunomodulatory Drugs Killer-cell Immunoglobulin-like Receptors (KIRs)KIR Alleles (KIR AA)

Start date: 2022-01-01
Primary completion: 2022-12-31
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.